Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Palbociclib | CDK4/6 | Cell cycle | 0.11065 | 0.2066 | 0.3469 | 0.0101 | 0.7428 | 0.05699 | 0.98815 |
MDA-MB-231 | AZD7762 | CHK1/2 | Cell cycle | 0.15977 | -0.4632 | 0.5380 | 0.2422 | 0.9378 | 0.33846 | 0.98568 |
MCF7 | Palbociclib | CDK4/6 | Cell cycle | 0.074952 | 0.2542 | 0.3461 | 0.0139 | 1.0473 | 0.035667 | 0.99237 |
MDA-MB-231 | Abemaciclib | CDK4/6 | Cell cycle | 0.046803 | -0.4875 | 0.6754 | 0.1393 | 0.3863 | 0.73058 | 0.97904 |
MCF 10A | AZD7762 | CHK1/2 | Cell cycle | 1.8064 | -0.1800 | 0.2246 | 0.0802 | 0.8472 | 6.6065 | 0.99793 |
MCF 10A | Palbociclib | CDK4/6 | Cell cycle | 1.9503 | 0.4544 | 0.1883 | -0.0047 | 0.6492 | 0.23713 | 0.99244 |
MCF 10A | Dinaciclib | pan CDK | Cell cycle | 0.016244 | -0.2300 | 0.5279 | 0.2344 | 5.0000 | 0.017523 | 0.99904 |
MCF7 | Abemaciclib | CDK4/6 | Cell cycle | 0.023572 | -0.2684 | 0.7018 | 0.0913 | 0.3795 | 0.13917 | 0.95433 |
MCF7 | AZD7762 | CHK1/2 | Cell cycle | 0.04144 | -0.1856 | 0.5977 | 0.1318 | 0.8993 | 0.048851 | 0.95892 |
MCF7 | Dinaciclib | pan CDK | Cell cycle | 0.0083068 | -0.2493 | 0.6441 | 0.1256 | 3.5461 | 0.009348 | 0.9995 |
Hs 578T | Dinaciclib | pan CDK | Cell cycle | 0.0089363 | -0.2388 | 0.6160 | 0.2121 | 4.9934 | 0.0096082 | 0.99916 |
Hs 578T | Volasertib | PLK | Cell cycle | 0.0025675 | -0.3123 | 0.8198 | 0.3337 | 3.0081 | 0.0029864 | 0.9987 |
HCC1806 | Abemaciclib | CDK4/6 | Cell cycle | 0.59453 | -0.4440 | 0.3921 | 0.1035 | 0.6190 | 3.5069 | 0.96621 |
MCF 10A | Abemaciclib | CDK4/6 | Cell cycle | 0.34027 | 0.1513 | 0.3811 | -0.0012 | 0.5714 | 0.28176 | 0.99756 |
HCC1806 | Volasertib | PLK | Cell cycle | 0.0027998 | -0.1323 | 0.7262 | 0.2950 | 5.0000 | 0.0029495 | 0.99776 |
MCF 10A | Volasertib | PLK | Cell cycle | 0.022128 | -0.0887 | 0.4466 | 0.1711 | 3.5358 | 0.023168 | 0.99997 |
HCC1806 | Palbociclib | CDK4/6 | Cell cycle | Inf | 0.6924 | 0.1460 | 0.0085 | 1.6543 | 0.024125 | 0.93749 |
Hs 578T | AZD7762 | CHK1/2 | Cell cycle | 0.015096 | -0.5983 | 0.8646 | 0.4133 | 1.8783 | 0.01967 | 0.95944 |
HCC1806 | Dinaciclib | pan CDK | Cell cycle | 0.013395 | -0.4585 | 0.6439 | 0.3114 | 3.4710 | 0.016174 | 0.99891 |
Hs 578T | Palbociclib | CDK4/6 | Cell cycle | 0.15611 | 0.3049 | 0.3195 | 0.0363 | 0.7223 | 0.037735 | 0.98196 |
MCF7 | Volasertib | PLK | Cell cycle | 0.0028671 | -0.0338 | 0.6070 | 0.1245 | 4.2176 | 0.002824 | 0.99423 |
Hs 578T | Abemaciclib | CDK4/6 | Cell cycle | 0.077629 | -0.5825 | 0.6343 | 0.1966 | 0.4160 | 1.0889 | 0.95772 |
HCC1806 | AZD7762 | CHK1/2 | Cell cycle | 0.016629 | -0.4822 | 0.8897 | 0.3907 | 1.6771 | 0.023183 | 0.99277 |
MDA-MB-231 | Dinaciclib | pan CDK | Cell cycle | 0.010273 | -0.4203 | 0.6627 | 0.2555 | 2.6877 | 0.012709 | 0.99722 |
MDA-MB-231 | Volasertib | PLK | Cell cycle | 0.0043583 | -0.0186 | 0.5873 | 0.1359 | 3.6103 | 0.0044117 | 0.99795 |